首页> 外国专利> AN ACCURATE AND COMPREHENSIVE CARDIAC TROPONIN I ASSAY ENABLED BY NANOTECHNOLOGY AND PROTEOMICS

AN ACCURATE AND COMPREHENSIVE CARDIAC TROPONIN I ASSAY ENABLED BY NANOTECHNOLOGY AND PROTEOMICS

机译:通过纳米技术和蛋白质组学实现的准确和全面的心肌肌钙蛋白I测定

摘要

This invention provides mass spectrometry (MS) compatible nanomaterials for the selective capture and enrichment of low abundance proteins as well as MS analysis of different proteoforms of proteins, particularly cardiac proteins and different proteoforms of cardiac troponin I (cTnI) arising from post-translational modifications and sequence variations. The surface of superparamagnetic nanoparticles is functionalized with probe molecules that specifically bind to the desired protein. In an embodiment, the nanoparticles are functionalized with probe molecules having high affinity and selectivity for cTnI within the human cardiac troponin complex. This allows for MS-analysis and characterization of cTnI proteoforms from human heart tissue lysates and human blood or serum samples, and provides an accurate assay for detection of cTnI with molecular details. Such assays are useful for accurate diagnosis of acute coronary syndrome and chronic diseases, including acute myocardial infarction and other cardiac injuries, as well as risk stratification and outcome assessment for patients.
机译:本发明提供了质谱(MS)相容的纳米材料,用于选择性捕获和富集低丰度蛋白以及从翻译后修饰产生的蛋白质不同蛋白质的不同蛋白质和不同蛋白质常规的MS分析,特别是心肌肌蛋白I(CTNI)和序列变化。通过特异性结合所需蛋白质的探针分子使超顺磁性纳米颗粒的表面具有官能化。在一个实施方案中,纳米颗粒用具有高亲和力的探针分子,对人心肌肌钙蛋白络合物中的CTNI具有高亲和力和选择性。这允许来自人体心脏组织裂解物和人血液或血清样品的CTNI蛋白质的MS-分析和表征,并提供用于检测CTNI的精确测定,用于用分子细节检测CTNI。这些测定可用于准确诊断急性冠状动脉综合征和慢性疾病,包括急性心肌梗死和其他心脏损伤,以及患者的风险分层和结果评估。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号